Status:
COMPLETED
Phase I Pilot Study to Evaluate the Prognostic Value of Perfusion CT for Primary Cervical Cancer
Lead Sponsor:
Stanford University
Conditions:
Cervical Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The investigators hope to learn whether perfusion CT is a useful way to assess primary cervical tumor microenvironment and whether there is a relationship between pretreatment perfusion CT measurement...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \>18 years old
- with biopsy-proven squamous, adenocarcinoma or adenosquamous cervical cancer
- no history of prior pelvic radiation and should be able to receive chemoradiation
- non-pregnant women who have not previously undergone a hysterectomy, as that would have removed the cervix.
- able to give informed consent
- Exclusion criteria:
- Subjects whose tumors are not FDG avid on the pre-therapy PET.
- Allergy or inability to receive iodinated CT contrast
Exclusion
Key Trial Info
Start Date :
August 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 4 2018
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01805141
Start Date
August 1 2013
End Date
October 4 2018
Last Update
October 31 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305